Combination of paeoniflorin and liquiritin alleviates neuropathic pain by lipid metabolism and calcium signaling coordination
Neuropathic pain (NP) affects 7%-10% of the general population and is still hard to cure. Here, we validated the therapeutic effect and demonstrated the mechanism of paeoniflorin and liquiritin combination (PL) on NP from the perspective of integrated lipidomics and transcriptomics for the first tim...
Saved in:
Main Authors: | Yan-Yan Chen (Author), Li-Mei Feng (Author), Ding-Qiao Xu (Author), Shi-Jun Yue (Author), Rui-Jia Fu (Author), Mei-Mei Zhang (Author), Yu-Ping Tang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liquiritin Alleviates Pain Through Inhibiting CXCL1/CXCR2 Signaling Pathway in Bone Cancer Pain Rat
by: Huadong Ni, et al.
Published: (2020) -
De novo biosynthesis of liquiritin in Saccharomyces cerevisiae
by: Yan Yin, et al.
Published: (2020) -
Liquiritin ameliorates painful diabetic neuropathy in SD rats by inhibiting NLRP3-MMP-9-mediated reversal of aquaporin-4 polarity in the glymphatic system
by: Shuai-Ying Jia, et al.
Published: (2024) -
Liquiritin Attenuates Lipopolysaccharides-Induced Cardiomyocyte Injury via an AMP-Activated Protein Kinase-Dependent Signaling Pathway
by: Shan-Qi Mou, et al.
Published: (2021) -
Paeoniflorin alleviates liver injury in hypercholesterolemic rats through the ROCK/AMPK pathway
by: Tong Liu, et al.
Published: (2022)